Maria Guadalupe Martinez

Maria Guadalupe Martinez

Auto-generated profile, based on publicly available information

Maria Guadalupe Martinez

UMR U1350, Pathobiology and Therapy of Liver Diseases (PaThLiv); INSERM, Lyon 1 University, Lyon, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
MMMaria Guadalupe Martinez
Maria Guadalupe Martinez
ABAnders Boyd
Anders Boyd
ECEmmanuel Combe
Emmanuel Combe
BTBarbara Testoni
Barbara Testoni
Fabien ZoulimFabien Zoulim
Fabien Zoulim

16 April 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
MAMariano Prado Acosta
Mariano Prado Acosta
EGEileen M. Geoghegan
Eileen M. Geoghegan
BLBernd Lepenies
Bernd Lepenies
SRSandra Ruzal
Sandra Ruzal
MKMargaret Kielian
Margaret Kielian
MMMaria Guadalupe Martinez
Maria Guadalupe Martinez
Alphaviruses and flaviviruses are important human pathogens that include Chikungunya virus (CHIKV), Dengue virus (DENV), and Zika virus (ZIKV), which can cause diseases in humans ranging from arthralgia to hemorrhagic fevers and microcephaly. It was previously shown that treatment with surface layer (S-layer) protein, present on the bacterial cell-envelope of Lactobacillus acidophilus, is able to inhibit viral and bacterial infections by blocking the pathogen’s interaction with DC-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), a trans-membrane protein that is a C-type calcium-dependent lectin. DC-SIGN is known to act as an attachment factor for several viruses including alphaviruses and flaviviruses. In the present study, we used alphaviruses as a model system to dissect the mechanism of S-layer inhibition. We first evaluated the protective effect of S-layer using 3T3 cells, either wild type or stably expressing DC-SIGN, and infecting with the alphaviruses Semliki Forest virus (SFV) and CHIKV and the flaviviruses ZIKV and DENV. DC-SIGN expression significantly enhanced infection by all four viruses. Treatment of the cells with S-layer prior to infection decreased infectivity of all viruses only in cells expressing DC-SIGN. In vitro ELISA experiments showed a direct interaction between S-layer and DC-SIGN; however, confocal microscopy and flow cytometry demonstrated that S-layer binding to the cells was independent of DC-SIGN expression. S-layer protein prevented SFV binding and internalization in DC-SIGN-expressing cells but had no effect on virus binding to DC-SIGN-negative cells. Inhibition of virus binding occurred in a time-dependent manner, with a significant reduction of infection requiring at least a 30-min pre-incubation of S-layer with DC-SIGN-expressing cells. These results suggest that S-layer has a different mechanism of action compared to mannan, a common DC-SIGN-binding compound that has an immediate effect in blocking viral infection. This difference could reflect slower kinetics of S-layer binding to the DC-SIGN present at the plasma membrane (PM). Alternatively, the S-layer/DC-SIGN interaction may trigger the activation of signaling pathways that are required for the inhibition of viral infection. Together our results add important information relevant to the potential use of L. acidophilus S-layer protein as an antiviral therapy.

26 April 2022 in mBio
Verified
Journal Article
Open access
MMMaria Guadalupe Martinez
Maria Guadalupe Martinez
ECEmmanuel Combe
Emmanuel Combe
AIAurore Inchauspe
Aurore Inchauspe
PMPhilippe Emmanuel Mangeot
Philippe Emmanuel Mangeot
EDElodie Delberghe
Elodie Delberghe
Fabien ZoulimFabien Zoulim
Fabien Zoulim
Hepatitis B virus infection can develop into chronic infection, cirrhosis, and hepatocellular carcinoma. Treatment of chronic hepatitis B requires novel approaches to directly target the viral minichromosome, which is responsible for the persistence of the disease.

25 February 2019 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
MMMaria G. Martinez
Maria G. Martinez
BTBarbara Testoni
Barbara Testoni
Fabien ZoulimFabien Zoulim
Fabien Zoulim

28 November 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MMMaria Guadalupe Martinez
Maria Guadalupe Martinez
ESElena Smekalova
Elena Smekalova
ECEmmanuel Combe
Emmanuel Combe
FGFrancine Gregoire
Francine Gregoire
Fabien ZoulimFabien Zoulim
Fabien Zoulim
BTBarbara Testoni
Barbara Testoni
Hepatitis B virus (HBV) remains a significant cause of mortality and morbidity worldwide, since chronic HBV infection is associated with elevated risk of cirrhosis and hepatocellular carcinoma. Current licensed therapies against HBV efficiently suppress viral replication; however, they do not have significant effects on the intrahepatic covalently closed circular DNA (cccDNA) of the viral minichromosome responsible for viral persistence. Thus, life-long treatment is required to avoid viral rebound. There is a significant need for novel therapies that can reduce, silence or eradicate cccDNA, thus preventing HBV reemergence after treatment withdrawal. In this review, we discuss the latest developments and applications of gene editing and related approaches for directly targeting HBV DNA and, more specifically, cccDNA in infected hepatocytes.

28 June 2022 in Viruses
Verified
Journal Article
Open access
PDF file
KSKamini Singh
Kamini Singh
MMMaria Guadalupe Martinez
Maria Guadalupe Martinez
JLJianan Lin
Jianan Lin
JGJames Gregory
James Gregory
TNTrang Uyen Nguyen
Trang Uyen Nguyen
HWHans-Guido Wendel
Hans-Guido Wendel
Zika virus (ZIKV) and dengue virus (DENV) are members of the Flaviviridae family of RNA viruses and cause severe disease in humans. ZIKV and DENV share over 90% of their genome sequences, however, the clinical features of Zika and dengue infections are very different reflecting tropism and cellular effects. Here, we used simultaneous RNA sequencing and ribosome footprinting to define the transcriptional and translational dynamics of ZIKV and DENV infection in human neuronal progenitor cells (hNPCs). The gene expression data showed induction of aminoacyl tRNA synthetases (ARS) and the translation activating PIM1 kinase, indicating an increase in RNA translation capacity. The data also reveal activation of different cell stress responses, with ZIKV triggering a BACH1/2 redox program, and DENV activating the ATF/CHOP endoplasmic reticulum (ER) stress program. The RNA translation data highlight activation of polyamine metabolism through changes in key enzymes and their regulators. This pathway is needed for eIF5A hypusination and has been implicated in viral translation and replication. Concerning the viral RNA genomes, ribosome occupancy readily identified highly translated open reading frames and a novel upstream ORF (uORF) in the DENV genome. Together, our data highlight both the cellular stress response and the activation of RNA translation and polyamine metabolism during DENV and ZIKV infection.